Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge J Castillo

Showing results (61-70 of 342) with videos related to

Pageof 35
Sort By:
Expert Opinion on Drug Safety|March 1, 2021
Reducing treatment toxicity in Waldenström macroglobulinemiaShayna Sarosiek, Steven P Treon, Jorge J Castillo
Hematology/Oncology Clinics of North America|September 8, 2018
Waldenström Macroglobulinemia: Lessons Learned from Basic and Clinical ResearchJorge J Castillo, Efstathios Kastritis, Steven P Treon
Current Treatment Options in Oncology|August 24, 2021
How to Sequence Therapies in Waldenström MacroglobulinemiaShayna Sarosiek, Steven P Treon, Jorge J Castillo
The Oncologist|July 31, 2016
Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based AnalysisAdam J Olszewski, Steven P Treon, Jorge J Castillo
Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2016
Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell LymphomaAdam J Olszewski, Kalyan C Mantripragada, Jorge J Castillo
American Journal of Hematology|November 26, 2013
Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results databaseJorge J Castillo, Eric S Winer, Adam J Olszewski
Clinical Case Reports|May 23, 2022
Bone marrow aspiration in a patient with systemic microsporidiumXimena E Gómez, Jorge J Castillo, Marco A Gómez
Leukemia Research|May 20, 2014
Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphomaAdam J Olszewski, Eric S Winer, Jorge J Castillo
Cancer Causes & Control : CCC|June 10, 2015
Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data BaseAdam J Olszewski, Eric S Winer, Jorge J Castillo
American Journal of Hematology|April 23, 2014
The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studiesSophia Fircanis, Priscilla Merriam, Naushaba Khan, et al.
Pageof 35

Showing results (61-70 of 342) with videos related to

Sort By:
Pageof 35
Expert Opinion on Drug Safety|March 1, 2021
Reducing treatment toxicity in Waldenström macroglobulinemiaShayna Sarosiek, Steven P Treon, Jorge J Castillo
Hematology/Oncology Clinics of North America|September 8, 2018
Waldenström Macroglobulinemia: Lessons Learned from Basic and Clinical ResearchJorge J Castillo, Efstathios Kastritis, Steven P Treon
Current Treatment Options in Oncology|August 24, 2021
How to Sequence Therapies in Waldenström MacroglobulinemiaShayna Sarosiek, Steven P Treon, Jorge J Castillo
The Oncologist|July 31, 2016
Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based AnalysisAdam J Olszewski, Steven P Treon, Jorge J Castillo
Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2016
Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell LymphomaAdam J Olszewski, Kalyan C Mantripragada, Jorge J Castillo
American Journal of Hematology|November 26, 2013
Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results databaseJorge J Castillo, Eric S Winer, Adam J Olszewski
Clinical Case Reports|May 23, 2022
Bone marrow aspiration in a patient with systemic microsporidiumXimena E Gómez, Jorge J Castillo, Marco A Gómez
Leukemia Research|May 20, 2014
Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphomaAdam J Olszewski, Eric S Winer, Jorge J Castillo
Cancer Causes & Control : CCC|June 10, 2015
Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data BaseAdam J Olszewski, Eric S Winer, Jorge J Castillo
American Journal of Hematology|April 23, 2014
The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studiesSophia Fircanis, Priscilla Merriam, Naushaba Khan, et al.
Pageof 35